Jürgen Behrens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jürgen Behrens has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Jean Schneikert
Nikolaus-Fiebiger-Center for Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany
5 shared publicationsMichel V. Hadjihannas
Nikolaus-Fiebiger-Center, Chair of Experimental Medicine II, Friedrich-Alexander Universität Erlangen-Nürnberg, Glückstr. 6, D-91054 Erlangen, Germany
4 shared publications- Alexandra Schambony
Max Planck Institute for the Science of Light
3 shared publications Astrid S. Pfister
Nikolaus-Fiebiger-Center for Molecular Medicine, University Erlangen-Nuremberg, 91054 Erlangen, Germany
3 shared publicationsBarbara Lustig
Clinical Center Nürnberg
3 shared publications- Dominic B. Bernkopf
Experimental Medicine II, Nikolaus-Fiebiger-Center, Friedrich-Alexander University Erlangen-Nürnberg
3 shared publications
Latest Publications
- Open Access
- 14 July 2015
- Published by Springer Nature in Cell Discovery
- Vol. 1 (1) , 15016
Structures of the APC–ARM domain in complexes with discrete Amer1/WTX fragments reveal that it uses a consensus mode to recognize its binding partners
The tumor suppressor APC employs its conserved armadillo repeat (ARM) domain to recognize many of its binding partners, including Amer1/WTX, which is mutated in Wilms' tumor and bone overgrowth syndrome. The APC–Amer1 complex has important roles in regulating Wnt signaling and cell adhesion. Three sites A1, A2, and A3 of Amer1 have been reported to mediate its interaction with APC-ARM. In this study, crystal structures of APC–ARM in complexes with Amer1-A1, -A2, and -A4, which is newly identified in this work, were determined. Combined with our GST pull-down, yeast two-hybrid, and isothermal titration calorimetry (ITC) assay results using mutants of APC and Amer1 interface residues, our structures demonstrate that Amer1-A1, -A2, and -A4, as well as other APC-binding proteins such as Asef and Sam68, all employ a common recognition pattern to associate with APC–ARM. In contrast, Amer1-A3 binds to the C-terminal side of APC–ARM through a bipartite interaction mode. Composite mutations on either APC or Amer1 disrupting all four interfaces abrogated their association in cultured cells and impaired the membrane recruitment of APC by Amer1. Our study thus comprehensively elucidated the recognition mechanism between APC and Amer1, and revealed a consensus recognition sequence employed by various APC–ARM binding partners.
- 14 July 2015
- Published by Springer Nature in Cell Discovery
- Vol. 1 (1) , 15016
Open AccessStructures of the APC–ARM domain in complexes with discrete Amer1/WTX fragments reveal that it uses a consensus mode to recognize its binding partners
The tumor suppressor APC employs its conserved armadillo repeat (ARM) domain to recognize many of its binding partners, including Amer1/WTX, which is mutated in Wilms' tumor and bone overgrowth syndrome. The APC–Amer1 complex has important roles in regulating Wnt signaling and cell adhesion. Three sites A1, A2, and A3 of Amer1 have been reported to mediate its interaction with APC-ARM. In this study, crystal structures of APC–ARM in complexes with Amer1-A1, -A2, and -A4, which is newly identified in this work, were determined. Combined with our GST pull-down, yeast two-hybrid, and isothermal titration calorimetry (ITC) assay results using mutants of APC and Amer1 interface residues, our structures demonstrate that Amer1-A1, -A2, and -A4, as well as other APC-binding proteins such as Asef and Sam68, all employ a common recognition pattern to associate with APC–ARM. In contrast, Amer1-A3 binds to the C-terminal side of APC–ARM through a bipartite interaction mode. Composite mutations on either APC or Amer1 disrupting all four interfaces abrogated their association in cultured cells and impaired the membrane recruitment of APC by Amer1. Our study thus comprehensively elucidated the recognition mechanism between APC and Amer1, and revealed a consensus recognition sequence employed by various APC–ARM binding partners.
- Open Access
- 24 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e111276
Activin B Antagonizes RhoA Signaling to Stimulate Mesenchymal Morphology and Invasiveness of Clear Cell Renal Cell Carcinomas
Activin B belongs to the TGFβ family of growth factors and is upregulated in clear cell renal cell carcinoma cells by hypoxia inducible factors. Expression of Activin B is required for tumor growth in vivo and tumor cell invasion in vitro. Here we show that activation of RhoA signaling counteracts Activin B mediated disassembly of actin stress fibers, mesenchymal cell morphology and invasiveness, whereas inhibition of RhoA rescues these effects in Activin B knockdown cells. Conversely, Activin B inhibits RhoA signaling suggesting that there is an antagonistic connection between both pathways. In addition we found that Rac1 plays an opposite role to RhoA, i.e. activation of Rac1 initiates loss of actin stress fibers, promotes a mesenchymal cell morphology and induces invasion in Activin B knockown cells, whereas inhibition of Rac1 abolishes these Activin B effects. Collectively, our data provide evidence that reduction of RhoA signaling by Activin B together with persistent Rac1 activity is a prerequisite for inducing an invasive phenotype in clear cell renal cell carcinoma.
- 24 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e111276
Open AccessActivin B Antagonizes RhoA Signaling to Stimulate Mesenchymal Morphology and Invasiveness of Clear Cell Renal Cell Carcinomas
Activin B belongs to the TGFβ family of growth factors and is upregulated in clear cell renal cell carcinoma cells by hypoxia inducible factors. Expression of Activin B is required for tumor growth in vivo and tumor cell invasion in vitro. Here we show that activation of RhoA signaling counteracts Activin B mediated disassembly of actin stress fibers, mesenchymal cell morphology and invasiveness, whereas inhibition of RhoA rescues these effects in Activin B knockdown cells. Conversely, Activin B inhibits RhoA signaling suggesting that there is an antagonistic connection between both pathways. In addition we found that Rac1 plays an opposite role to RhoA, i.e. activation of Rac1 initiates loss of actin stress fibers, promotes a mesenchymal cell morphology and induces invasion in Activin B knockown cells, whereas inhibition of Rac1 abolishes these Activin B effects. Collectively, our data provide evidence that reduction of RhoA signaling by Activin B together with persistent Rac1 activity is a prerequisite for inducing an invasive phenotype in clear cell renal cell carcinoma.
- Open Access
- 10 April 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e94413
Different Roles for the Axin Interactions with the SAMP versus the Second Twenty Amino Acid Repeat of Adenomatous Polyposis Coli
Wnt signalling is prevented by the proteosomal degradation of β-catenin, which occurs in a destruction complex containing adenomatous polyposis coli (APC), APC-like (APCL), Axin and Axin2. Truncating mutations of the APC gene result in the constitutive stabilisation of β-catenin and the initiation of colon cancer, although tumour cells tolerate the expression of wild-type APCL. Using the colocalisation of overexpressed Axin, APC and APCL constructs as a readout of interaction, we found that Axin interacted with the second twenty amino acid repeat (20R2) of APC and APCL. This interaction involved a domain adjacent to the C-terminal DIX domain of Axin. We identified serine residues within the 20R2 of APCL that were involved in Axin colocalisation, the phosphorylation of truncated APCL and the down-regulation of β-catenin. Our results indicated that Axin, but not Axin2, displaced APC, but not APCL, from the cytoskeleton and stimulated its incorporation into bright cytoplasmic dots that others have recognised as β-catenin destruction complexes. The SAMP repeats in APC interact with the N-terminal RGS domain of Axin. Our data showed that a short domain containing the first SAMP repeat in truncated APC was required to stimulate Axin oligomerisation. This was independent of Axin colocalisation with 20R2. Our data also suggested that the RGS domain exerted an internal inhibitory constraint on Axin oligomerisation. Considering our data and those from others, we discuss a working model whereby β-catenin phosphorylation involves Axin and the 20R2 of APC or APCL and further processing of phospho-β-catenin occurs upon the oligomerisation of Axin that is induced by binding the SAMP repeats in APC.
- 10 April 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e94413
Open AccessDifferent Roles for the Axin Interactions with the SAMP versus the Second Twenty Amino Acid Repeat of Adenomatous Polyposis Coli
Wnt signalling is prevented by the proteosomal degradation of β-catenin, which occurs in a destruction complex containing adenomatous polyposis coli (APC), APC-like (APCL), Axin and Axin2. Truncating mutations of the APC gene result in the constitutive stabilisation of β-catenin and the initiation of colon cancer, although tumour cells tolerate the expression of wild-type APCL. Using the colocalisation of overexpressed Axin, APC and APCL constructs as a readout of interaction, we found that Axin interacted with the second twenty amino acid repeat (20R2) of APC and APCL. This interaction involved a domain adjacent to the C-terminal DIX domain of Axin. We identified serine residues within the 20R2 of APCL that were involved in Axin colocalisation, the phosphorylation of truncated APCL and the down-regulation of β-catenin. Our results indicated that Axin, but not Axin2, displaced APC, but not APCL, from the cytoskeleton and stimulated its incorporation into bright cytoplasmic dots that others have recognised as β-catenin destruction complexes. The SAMP repeats in APC interact with the N-terminal RGS domain of Axin. Our data showed that a short domain containing the first SAMP repeat in truncated APC was required to stimulate Axin oligomerisation. This was independent of Axin colocalisation with 20R2. Our data also suggested that the RGS domain exerted an internal inhibitory constraint on Axin oligomerisation. Considering our data and those from others, we discuss a working model whereby β-catenin phosphorylation involves Axin and the 20R2 of APC or APCL and further processing of phospho-β-catenin occurs upon the oligomerisation of Axin that is induced by binding the SAMP repeats in APC.
- 1 January 2014
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 128 (1) , 33-9
Negative feedback regulation of the Wnt pathway by conductin/axin2 involves insensitivity to upstream signalling
Axin and conductin/axin2 are structurally related inhibitors of Wnt/β-catenin signalling that promote degradation of β-catenin. Whereas axin is constitutively expressed, conductin is a Wnt target gene implicated in negative feedback regulation. Here we show that axin and conductin differ in their functional interaction with the upstream Wnt pathway component Dvl. Conductin shows reduced binding to Dvl2 compared to axin, and degradation of β-catenin by conductin is only poorly blocked by Dvl2. We propose that insensitivity to Dvl is an important feature of conductin's role as a negative feedback regulator of Wnt signalling.
- 1 January 2014
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 128 (1) , 33-9
Negative feedback regulation of the Wnt pathway by conductin/axin2 involves insensitivity to upstream signalling
Axin and conductin/axin2 are structurally related inhibitors of Wnt/β-catenin signalling that promote degradation of β-catenin. Whereas axin is constitutively expressed, conductin is a Wnt target gene implicated in negative feedback regulation. Here we show that axin and conductin differ in their functional interaction with the upstream Wnt pathway component Dvl. Conductin shows reduced binding to Dvl2 compared to axin, and degradation of β-catenin by conductin is only poorly blocked by Dvl2. We propose that insensitivity to Dvl is an important feature of conductin's role as a negative feedback regulator of Wnt signalling.
- 12 December 2013
- Published by Wiley in The FEBS Journal
- Vol. 281 (3) , 787-801
Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC‐binding proteins, is a positive regulator of Wnt–β‐catenin signalling
The adenomatous polyposis coli (APC) membrane recruitment (Amer) family proteins Amer1/Wilms tumour gene on the X chromosome and Amer2 are binding partners of the APC tumour suppressor protein, and act as negative regulators in the Wnt signalling cascade. So far, nothing has been known about the third member of the family, Amer3. Here we show that Amer3 binds to the armadillo repeat domain of APC, similarly to Amer1 and Amer2. Amer3 also binds to the Wnt pathway regulator conductin/axin2. Furthermore, we identified Amer1 as binding partner of Amer3. Whereas Amer1 and Amer2 are linked to the plasma membrane by an N‐terminal membrane localization domain, Amer3 lacks this domain. Amer3 localizes to the cytoplasm and nucleus of epithelial cells, and this is dependent on specific nuclear import and export sequences. Functionally, exogenous Amer3 enhances the expression of a β‐catenin/T‐cell factor‐dependent reporter gene, and knockdown of endogenous Amer3 reduces Wnt target gene expression in colorectal cancer cells. Thus, Amer3 acts as an activator of Wnt signalling, in contrast to Amer1 and Amer2, which are inhibitors, suggesting a nonredundant role of Amer proteins in the regulation of this pathway. Our data, together with those of previous studies, provide a comprehensive picture of similarities and differences within the Amer protein family.Structured digital AMER3 physically interacts with APC by two hybrid (1, 2). AMER3 physically interacts with APC by anti tag coimmunoprecipitation (1, 2, 3). APC physically interacts with AMER3 by anti bait coimmunoprecipitation (View interaction). AMER3 physically interacts with APC, AMER1 and Conductin by anti bait coimmunoprecipitation (View interaction). AMER3 physically interacts with AMER1 by anti tag coimmunoprecipitation (1, 2). AMER3 and APC colocalize by fluorescence microscopy (View interaction). Conductin physically interacts with AMER3 by anti tag coimmunoprecipitation (View interaction). APC physically interacts with AMER2 by anti tag coimmunoprecipitation (View interaction). Conductin physically interacts with AMER3 by anti tag coimmunoprecipitation (1, 2). AMER1 and AMER3 colocalize by fluorescence microscopy (View interaction). APC physically interacts with AMER1 by anti tag coimmunoprecipitation (View interaction).
- 12 December 2013
- Published by Wiley in The FEBS Journal
- Vol. 281 (3) , 787-801
Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC‐binding proteins, is a positive regulator of Wnt–β‐catenin signalling
The adenomatous polyposis coli (APC) membrane recruitment (Amer) family proteins Amer1/Wilms tumour gene on the X chromosome and Amer2 are binding partners of the APC tumour suppressor protein, and act as negative regulators in the Wnt signalling cascade. So far, nothing has been known about the third member of the family, Amer3. Here we show that Amer3 binds to the armadillo repeat domain of APC, similarly to Amer1 and Amer2. Amer3 also binds to the Wnt pathway regulator conductin/axin2. Furthermore, we identified Amer1 as binding partner of Amer3. Whereas Amer1 and Amer2 are linked to the plasma membrane by an N‐terminal membrane localization domain, Amer3 lacks this domain. Amer3 localizes to the cytoplasm and nucleus of epithelial cells, and this is dependent on specific nuclear import and export sequences. Functionally, exogenous Amer3 enhances the expression of a β‐catenin/T‐cell factor‐dependent reporter gene, and knockdown of endogenous Amer3 reduces Wnt target gene expression in colorectal cancer cells. Thus, Amer3 acts as an activator of Wnt signalling, in contrast to Amer1 and Amer2, which are inhibitors, suggesting a nonredundant role of Amer proteins in the regulation of this pathway. Our data, together with those of previous studies, provide a comprehensive picture of similarities and differences within the Amer protein family.Structured digital AMER3 physically interacts with APC by two hybrid (1, 2). AMER3 physically interacts with APC by anti tag coimmunoprecipitation (1, 2, 3). APC physically interacts with AMER3 by anti bait coimmunoprecipitation (View interaction). AMER3 physically interacts with APC, AMER1 and Conductin by anti bait coimmunoprecipitation (View interaction). AMER3 physically interacts with AMER1 by anti tag coimmunoprecipitation (1, 2). AMER3 and APC colocalize by fluorescence microscopy (View interaction). Conductin physically interacts with AMER3 by anti tag coimmunoprecipitation (View interaction). APC physically interacts with AMER2 by anti tag coimmunoprecipitation (View interaction). Conductin physically interacts with AMER3 by anti tag coimmunoprecipitation (1, 2). AMER1 and AMER3 colocalize by fluorescence microscopy (View interaction). APC physically interacts with AMER1 by anti tag coimmunoprecipitation (View interaction).
- 14 May 2013
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 6 (275) , pe17
Everything You Would Like to Know About Wnt SignalingReview and commentary on Wnt Signaling , edited by Roel Nusse, Xi He, and Renée van Amerongen. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2013, 454 pp. ISBN: 978-1-936113-23-1.
Wnt signaling is among the handful of key signaling pathways that play roles in almost all aspects of metazoan biology. Wnt signaling regulates normal embryonic development, tissue homeostasis, and regeneration, and the pathway is highly conserved throughout evolution. Aberrations of Wnt signaling cause various diseases, including cancer. Because of this diversity of functions, research on Wnt signaling has emerged from a discipline of specialists initiated some 30 years ago into the realm of many life science investigators. A plethora of papers dealing with Wnt signaling are published every year, making it difficult for both established investigators and newcomers to keep abreast of all developments in the field. The new book Wnt Signaling, published by Cold Spring Harbor Laboratory Press and edited by Roel Nusse, Xi He, and Renée van Amerongen, provides a collection of excellent reviews that cover biochemical, functional, and pathophysiological aspects of Wnt signaling.
- 14 May 2013
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 6 (275) , pe17
Everything You Would Like to Know About Wnt SignalingReview and commentary on Wnt Signaling , edited by Roel Nusse, Xi He, and Renée van Amerongen. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2013, 454 pp. ISBN: 978-1-936113-23-1.
Wnt signaling is among the handful of key signaling pathways that play roles in almost all aspects of metazoan biology. Wnt signaling regulates normal embryonic development, tissue homeostasis, and regeneration, and the pathway is highly conserved throughout evolution. Aberrations of Wnt signaling cause various diseases, including cancer. Because of this diversity of functions, research on Wnt signaling has emerged from a discipline of specialists initiated some 30 years ago into the realm of many life science investigators. A plethora of papers dealing with Wnt signaling are published every year, making it difficult for both established investigators and newcomers to keep abreast of all developments in the field. The new book Wnt Signaling, published by Cold Spring Harbor Laboratory Press and edited by Roel Nusse, Xi He, and Renée van Amerongen, provides a collection of excellent reviews that cover biochemical, functional, and pathophysiological aspects of Wnt signaling.
- Open Access
- 1 October 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (42) , 35333-35340
Amer2 Protein Interacts with EB1 Protein and Adenomatous Polyposis Coli (APC) and Controls Microtubule Stability and Cell Migration
- 1 October 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (42) , 35333-35340
Open AccessAmer2 Protein Interacts with EB1 Protein and Adenomatous Polyposis Coli (APC) and Controls Microtubule Stability and Cell Migration
- Open Access
- 10 February 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (4) , 347-354
Cell cycle control of Wnt/β‐catenin signalling by conductin/axin2 through CDC20
Wnt/β‐catenin signalling regulates cell proliferation by modulating the cell cycle and is negatively regulated by conductin/axin2/axil. We show that conductin levels peak at G2/M followed by a rapid decline during return to G1. In line with this, Wnt/β‐catenin target genes are low at G2/M and high at G1/S, and β‐catenin phosphorylation oscillates during the cell cycle in a conductin‐dependent manner. Conductin is degraded by the anaphase‐promoting complex/cyclosome cofactor CDC20. Knockdown of CDC20 blocks Wnt signalling through conductin. CDC20‐resistant conductin inhibits Wnt signalling and attenuates colony formation of colorectal cancer cells. We propose that CDC20‐mediated degradation of conductin regulates Wnt/β‐catenin signalling for maximal activity during G1/S.
- 10 February 2012
- Published by Springer Nature in EMBO Reports
- Vol. 13 (4) , 347-354
Open AccessCell cycle control of Wnt/β‐catenin signalling by conductin/axin2 through CDC20
Wnt/β‐catenin signalling regulates cell proliferation by modulating the cell cycle and is negatively regulated by conductin/axin2/axil. We show that conductin levels peak at G2/M followed by a rapid decline during return to G1. In line with this, Wnt/β‐catenin target genes are low at G2/M and high at G1/S, and β‐catenin phosphorylation oscillates during the cell cycle in a conductin‐dependent manner. Conductin is degraded by the anaphase‐promoting complex/cyclosome cofactor CDC20. Knockdown of CDC20 blocks Wnt signalling through conductin. CDC20‐resistant conductin inhibits Wnt signalling and attenuates colony formation of colorectal cancer cells. We propose that CDC20‐mediated degradation of conductin regulates Wnt/β‐catenin signalling for maximal activity during G1/S.
- Open Access
- 1 January 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (3) , 1734-1741
Amer2 Protein Is a Novel Negative Regulator of Wnt/β-Catenin Signaling Involved in Neuroectodermal Patterning
- 1 January 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (3) , 1734-1741
Open AccessAmer2 Protein Is a Novel Negative Regulator of Wnt/β-Catenin Signaling Involved in Neuroectodermal Patterning
- Open Access
- 1 June 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (22) , 19204-19214
Structural and Functional Characterization of the Wnt Inhibitor APC Membrane Recruitment 1 (Amer1)
- 1 June 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (22) , 19204-19214
Open AccessStructural and Functional Characterization of the Wnt Inhibitor APC Membrane Recruitment 1 (Amer1)